Total Payments
$6,260
2024 Payments
$258.04
Companies
30
Transactions
234
Medicare Patients
846
Medicare Billing
$552,614
Payment Breakdown by Category
Food & Beverage$4,981 (79.6%)
Consulting$1,230 (19.6%)
Education$48.63 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,981 | 230 | 79.6% |
| Consulting Fee | $1,230 | 1 | 19.6% |
| Education | $48.63 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,667 | 21 | $0 (2023) |
| Allergan, Inc. | $603.63 | 31 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $572.08 | 22 | $0 (2019) |
| ABBVIE INC. | $437.40 | 19 | $0 (2024) |
| Lilly USA, LLC | $409.85 | 14 | $0 (2024) |
| UCB, Inc. | $401.56 | 18 | $0 (2021) |
| IMPEL PHARMACEUTICALS INC. | $304.81 | 14 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $257.17 | 17 | $0 (2019) |
| Amgen Inc. | $233.79 | 7 | $0 (2021) |
| Bausch Health US, LLC | $204.40 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.04 | 9 | ABBVIE INC. ($170.01) |
| 2023 | $1,710 | 24 | Teva Pharmaceuticals USA, Inc. ($1,230) |
| 2022 | $109.64 | 5 | ABBVIE INC. ($67.95) |
| 2021 | $195.54 | 9 | Allergan, Inc. ($48.16) |
| 2020 | $214.45 | 11 | Lilly USA, LLC ($120.16) |
| 2019 | $722.68 | 32 | Amgen Inc. ($112.30) |
| 2018 | $2,020 | 91 | Allergan Inc. ($378.57) |
| 2017 | $1,030 | 53 | UCB, Inc. ($211.62) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $42.25 | General |
| Category: PAIN | ||||||
| 11/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $36.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PAIN | ||||||
| 07/02/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY, QULIPTA | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/23/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Neuroscience | ||||||
| 04/16/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/24/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/21/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: Neurology | ||||||
| 12/14/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $8.31 | General |
| Category: Neurology | ||||||
| 11/28/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Neurology | ||||||
| 11/13/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: Neurology | ||||||
| 10/17/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Neurology | ||||||
| 10/11/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Neurology | ||||||
| 09/11/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Neurology | ||||||
| 08/31/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/22/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Neurology | ||||||
| 07/29/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Neurology | ||||||
| 06/29/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| Category: Central Nervous System | ||||||
| 06/13/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 250 | 27,614 | $598,290 | $182,444 |
| 2022 | 7 | 208 | 21,901 | $465,928 | $141,802 |
| 2021 | 7 | 222 | 22,099 | $466,438 | $140,818 |
| 2020 | 7 | 166 | 13,230 | $301,864 | $87,550 |
Total Patients
846
Total Services
84,844
Medicare Billing
$552,614
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 41 | 27,200 | $408,000 | $132,677 | 32.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 41 | 136 | $88,400 | $19,309 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 98 | $47,922 | $15,414 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 79 | $28,756 | $8,759 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $12,546 | $3,338 | 26.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 27 | 67 | $8,714 | $1,986 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $3,952 | $960.30 | 24.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 33 | 21,597 | $323,955 | $104,991 | 32.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 33 | 108 | $68,796 | $15,167 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 79 | $37,525 | $11,806 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 50 | $17,650 | $4,937 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 32 | $7,680 | $2,299 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $7,370 | $1,900 | 25.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 15 | 24 | $2,952 | $701.56 | 23.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 36 | 21,790 | $326,850 | $103,703 | 31.7% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 36 | 108 | $66,744 | $15,293 | 22.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 68 | $31,348 | $9,701 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 52 | $17,836 | $5,781 | 32.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $12,350 | $2,924 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 34 | $7,922 | $2,564 | 32.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 17 | 28 | $3,388 | $852.39 | 25.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 25 | 13,005 | $195,075 | $61,389 | 31.5% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 25 | 65 | $40,170 | $8,911 | 22.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 59 | $28,556 | $7,677 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 57 | $20,691 | $4,896 | 23.7% |
About Dr. Nelli Perkins, M.D
Dr. Nelli Perkins, M.D is a Neurology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1740592112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelli Perkins, M.D has received a total of $6,260 in payments from pharmaceutical and medical device companies, with $258.04 received in 2024. These payments were reported across 234 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,981).
As a Medicare-enrolled provider, Perkins has provided services to 846 Medicare beneficiaries, totaling 84,844 services with total Medicare billing of $552,614. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location San Francisco, CA
- Active Since 07/13/2010
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1740592112
Products in Payments
- AJOVY (Biological) $1,230
- BOTOX (Biological) $605.92
- NUEDEXTA (Drug) $394.40
- AJOVY (Drug) $351.97
- Trudhesa (Drug) $304.81
- EMGALITY (Drug) $237.06
- Briviact (Drug) $227.16
- TROKENDI XR (Drug) $218.21
- MIGRANAL (Drug) $204.40
- Aimovig (Biological) $203.60
- BOTOX THERAPEUTIC (Biological) $181.42
- ONZETRA Xsail (Drug) $177.68
- Neupro (Drug) $149.56
- GOCOVRI (Drug) $145.60
- Fycompa (Drug) $116.56
- ONFI (Drug) $113.52
- RYTARY (Drug) $109.88
- INGREZZA (Drug) $100.52
- QULIPTA (Drug) $98.55
- NURTEC ODT (Drug) $84.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Francisco
Dr. Bruce Cree, M.d, M.D
Neurology — Payments: $609,101
Neurology $609,101
Dr. Scott Zamvil, Md, MD
Neurology — Payments: $591,541
Neurology $591,541
Dr. S Claiborne Johnston, M.d, M.D
Neurology — Payments: $545,407
Neurology $545,407
Dr. Douglas Goodin
Neurology — Payments: $467,336
Neurology $467,336
Mr. Kenneth Laxer, M.d, M.D
Neurology — Payments: $419,550
Neurology $419,550
Dr. Armen Moughamian, Md, MD
Neurology — Payments: $333,078
Neurology $333,078